New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen

7d ago

MYGN

PremiumPress Releases

Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

1M ago

MYGN

PremiumPress Releases

Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device

1M ago

MYGN

PremiumPress Releases

Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance

2M ago

MYGN

PremiumPress Releases

Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3

2M ago

MYGN

PremiumPre-Earnings

MYGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

2M ago

MYGN

PremiumPress Releases

Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

2M ago

MYGN

More MYGN News >

0K3W News on the Web

2024-04-17

Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor

Yahoo Finance

Neutral

2024-04-16

New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen

Yahoo Finance

Neutral

2024-04-11

Atossa (ATOS) Reports Positive Results From EVANGELINE Study

Zacks

Neutral

2024-04-11

Myriad Genetics Announces Favorable Research Results

Yahoo Finance

Bullish

2024-04-11

Myriad Genetics (MYGN) Announces Favorable Research Results

Zacks

Bullish

2024-04-09

Here's Why You Should Retain Myriad Genetics Stock Now

Yahoo Finance

Neutral

2024-04-09

Here's Why You Should Retain Myriad Genetics (MYGN) Stock Now

Zacks

Neutral

2024-04-09

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

Yahoo Finance

Bearish

News Score - Last 7 Days

Neutral

GB:0K3W

Sector Average

Media Buzz

This Week1 articles

Weekly Average3.5 articles

News Sentiment

This Week50%

Sector Average59%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0K3W’s Media Buzz Sentiment?

1 articles about GB:0K3W were published this week. In an average week, 3.5 articles are published.

What is GB:0K3W’s weekly average amount of articles?

In an average week, 3.5 articles about GB:0K3W are published.

What is GB:0K3W’s News Sentiment?

50% of articles about GB:0K3W were positive this week, compared to its sector average of 59%.

Healthcare Stocks that are Trending in the News

IMVTImmunovant

INSPInspire Medical Systems

EVOEvotec AG

ISRGIntuitive Surgical

ABTAbbott Labs

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing